We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Denies Petition Seeking Withdrawal of Jazz’s Lung Cancer Drug Approval
FDA Denies Petition Seeking Withdrawal of Jazz’s Lung Cancer Drug Approval
The FDA has rejected a citizen petition pressing the agency to revoke the accelerated approval for Jazz Pharmaceuticals’ and PharmaMar’s Zepzelca (lurbinectedin), a treatment for adults with metastatic small cell lung cancer (SCLC).